Growth and Revenue Regenesis has established a solid revenue base between 25 million and 50 million dollars, indicating market demand for their energy-based medical devices and services, presenting opportunities to expand sales within existing customer segments and new healthcare markets.

Innovation Recognition The company's awards and recognition, such as being named Arizona Bioscience Company of the Year, highlight its reputation for innovation and industry leadership, making it a credible partner for strategic collaborations and sales efforts.

Funding and Investment With over 5 million dollars in funding, Regenesis demonstrates investor confidence and financial stability, providing a strong foundation for scaling sales efforts and introducing new advanced energy-based products to the healthcare sector.

Strategic Partnerships Recent sponsorship involvement with the Foundation for Peripheral Neuropathy showcases potential for forming strategic alliances with health foundations and organizations, enabling targeted outreach and joint sales opportunities for pain management solutions.

Technological Integration The company's use of advanced tech stacks such as Microsoft Dynamics 365 Finance and Google Cloud suggests a focus on streamlined operations and data-driven decision-making, which can be leveraged to refine sales strategies and tailor offerings to healthcare providers.